A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington’s Disease
Condition(s):Huntington DiseaseLast Updated:October 2, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Huntington DiseaseLast Updated:October 2, 2023Recruiting
Condition(s):Major Depressive DisorderLast Updated:December 8, 2023Recruiting
Condition(s):TinnitusLast Updated:December 22, 2023Completed
Condition(s):Mild Cognitive Impairment; Mild Dementia; Alzheimer’s DiseaseLast Updated:February 20, 2024Recruiting
Condition(s):Essential TremorLast Updated:September 29, 2023Recruiting
Condition(s):Huntington DiseaseLast Updated:December 6, 2023Recruiting
Condition(s):Parkinson Disease; Cognitive DysfunctionLast Updated:March 12, 2024Completed
Condition(s):Essential TremorLast Updated:March 4, 2024Active, not recruiting
Condition(s):Huntington’s DiseaseLast Updated:January 16, 2024Recruiting
Condition(s):Postpartum DepressionLast Updated:July 19, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.